A drug with the SMILES NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCC[C@@H](C(N)=O)NC1=O has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 15.776\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCC[C@@H](C(N)=O)NC1=O
NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCC[C@@H](C(N)=O)NC1=O
(5S,8S,11S)-8-(3-amino-3-oxopropyl)-11-(hydroxymethyl)-18-iodo-16-nitro-7,10,13-trioxo-2,6,9,12-tetrazabicyclo[12.4.0]octadeca-1(14),15,17-triene-5-carboxamide